These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 20210928
1. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Pavenski K, Warkentin TE, Shen H, Liu Y, Heddle NM. Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928 [Abstract] [Full Text] [Related]
2. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Arnold DM, Crowther MA, Cook RJ, Sigouin C, Heddle NM, Molnar L, Cook DJ. Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061 [Abstract] [Full Text] [Related]
3. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion. Enein AA, Hussein EA, El Shafie S, Hallouda M. J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120 [Abstract] [Full Text] [Related]
6. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions. Dunbar NM, Katus MC, Freeman CM, Szczepiorkowski ZM. Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728 [Abstract] [Full Text] [Related]
7. Patient and product factors affecting platelet transfusion results. Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S, Halter J, Tichelli A, Gratwohl A. Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413 [Abstract] [Full Text] [Related]
8. Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey. Lozano M, Heddle N, Williamson LM, Wang G, AuBuchon JP, Dumont LJ, Biomedical Excellence for Safer Transfusion Collaborative. Transfusion; 2010 Aug; 50(8):1743-8. PubMed ID: 20456712 [Abstract] [Full Text] [Related]
9. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs. Julmy F, Ammann RA, Taleghani BM, Fontana S, Hirt A, Leibundgut K. Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963 [Abstract] [Full Text] [Related]
10. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials. Cid J, Lozano M. Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827 [Abstract] [Full Text] [Related]
11. ABO and platelet transfusion revisited. Heal JM, Rowe JM, Blumberg N. Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561 [Abstract] [Full Text] [Related]
12. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions. Brooks EG, MacPherson BR, Fung MK. Transfusion; 2008 Oct; 48(10):2159-66. PubMed ID: 18631168 [Abstract] [Full Text] [Related]
13. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Gurkan E, Patah PA, Saliba RM, Ramos CA, Anderson BS, Champlin R, de Lima M, Lichtiger B. Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530 [Abstract] [Full Text] [Related]
14. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Gerday E, Baer VL, Lambert DK, Paul DA, Sola-Visner MC, Pysher TJ, Christensen RD. Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422 [Abstract] [Full Text] [Related]
15. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients. Fontaine MJ, Kuo J, Chen G, Galel SA, Miller E, Sequeira F, Viele M, Goodnough LT, Tyan DB. Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749 [Abstract] [Full Text] [Related]
16. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial. Lee EJ, Schiffer CA. Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333 [Abstract] [Full Text] [Related]
17. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Sato A, Iseki T, Yamaguchi T, Tojo A, Asano S. Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845 [Abstract] [Full Text] [Related]
18. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Maurer-Spurej E, Labrie A, Pittendreigh C, Chipperfield K, Smith C, Heddle N, Liu Y, Yi QL, Barnett M. Transfusion; 2009 Nov; 49(11):2276-84. PubMed ID: 19903289 [Abstract] [Full Text] [Related]
19. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial. Heddle NM, Cook RJ, Blajchman MA, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Kelton JG. Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987 [Abstract] [Full Text] [Related]
20. Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage. Magid-Bernstein J, Beaman CB, Carvalho-Poyraz F, Boehme A, Hod EA, Francis RO, Elkind MSV, Agarwal S, Park S, Claassen J, Connolly ES, Roh D. Blood; 2021 May 13; 137(19):2699-2703. PubMed ID: 33649761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]